Vigil Neuroscience Share Price Today
(NASDAQ: VIGL)

Name: Vigil Neuroscience Share Price Today (NASDAQ: VIGL) - Vigil Neuroscience Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Vigil Neuroscience share price is $1.71 & ₹146.15 as on 18 Apr 2025, 2.30 'hrs' IST

$1.71

▲

0.2

(13.25%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Vigil Neuroscience share price in Dollar and Rupees. Guide to invest in Vigil Neuroscience stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vigil Neuroscience, along with analyst recommendations, forecasts, and comprehensive financials.

Vigil Neuroscience share price movements

Today's Low: $1.50
Today's High: $1.74
$1.71
12.28%
Downside
Day's Volatility :13.79%
Upside
1.72%
52 Weeks Low: $1.31
52 Weeks High: $6.06
$1.71
23.27%
Downside
52 Weeks Volatility :78.35%
Upside
71.78%

Vigil Neuroscience (VIGL) Returns

Period	Vigil Neuroscience, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-17.79%	-2.8%	0.0%
6 Months	-55.47%	-11.0%	0.0%
1 Year	-39.36%	-1.9%	0.0%
3 Years	-72.15%	-1.5%	-12.9%

Vigil Neuroscience (VIGL) Key Statistics

in dollars & INR

Previous Close	$1.51
Open	$1.5
Today's High	$1.74
Today's Low	$1.5
Market Capitalization	$79.8M
Today's Volume	$76.8K
52 Week High	$6.06
52 Week Low	$1.312
Revenue TTM	$0.0
EBITDA	$-89.2M
Earnings Per Share (EPS)	$-2.34
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-89.69%

How to invest in Vigil Neuroscience Stock (VIGL) from India?

It is very easy for Indian residents to invest directly in Vigil Neuroscience from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vigil Neuroscience stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vigil Neuroscience or VIGL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vigil Neuroscience or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vigil Neuroscience shares which would translate to 0.500 fractional shares of Vigil Neuroscience as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vigil Neuroscience, in just a few clicks!

Returns in Vigil Neuroscience (VIGL) for Indian investors in Rupees

The Vigil Neuroscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Vigil Neuroscience investment value today

Current value as on today

₹62,979

Returns

₹37,021

(-37.02%)

Returns from Vigil Neuroscience Stock

₹39,362 (-39.36%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Vigil Neuroscience (VIGL)

63%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Vigil Neuroscience Stock from India on INDmoney has increased by 63% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Vigil Neuroscience

Northpond Ventures, LLC
9.03%
Siren, L.L.C.
4.27%
Bvf Inc
3.89%
Citadel Advisors Llc
3.23%
Sphera Funds Management Ltd.
3.22%
683 Capital Management LLC
3.00%

Analyst Recommendation on Vigil Neuroscience

Rating

Trend

Buy

85%Buy

7%Hold

7%Sell

Based on 14 Wall street analysts offering stock ratings for Vigil Neuroscience(by analysts ranked 0 to 5 stars)

Analyst Forecast on Vigil Neuroscience Stock (VIGL)

What analysts predicted

Upside of 825.95%

Target:

$15.83

Current:

$1.71

Insights on Vigil Neuroscience Stock (Ticker Symbol: VIGL)

Price Movement
In the last 6 months, VIGL stock has moved down by -61.9%
VIGL vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 122.6%
VIGL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 107.5%

Vigil Neuroscience Technicals Summary

Sell

Neutral

Buy

Vigil Neuroscience is currently in a neutral trading position according to technical analysis indicators.

Vigil Neuroscience (VIGL) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vigil Neuroscience, Inc.	-17.93%	-55.47%	-39.36%	-72.15%	-86.48%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vigil Neuroscience, Inc.	NA	NA	NA	-2.21	-0.9	-0.43	NA	1.75
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vigil Neuroscience, Inc.	Buy	$79.8M	-86.48%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

About Vigil Neuroscience

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain in the United States. The company's lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. It also developing VG-3927, an orally available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Watertown, Massachusetts.

Organization	Vigil Neuroscience
Employees	69
CEO	Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Industry	Services

Management People of Vigil Neuroscience

Name	Title
Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.	President, CEO & Director
Ms. Jennifer Ziolkowski CPA	Chief Financial Officer
Dr. Petra Kaufmann M.D., M.S.	Chief Medical Officer
Ms. Sharon Morani	Senior Director of Facilities & Operations
Dr. David Gray Ph.D.	Chief Scientific Officer
Eric Brophy	Senior Manager of Information Technology
Ms. Leah Gibson	Vice President of Investor Relations and Corporate Communications
Ms. April Effort M.B.A., M.S.	VP & Head of Corporate Development
Mr. Evan A. Thackaberry DABT, Ph.D.	Senior VP & Head of Early Development
Christian Mirescu Ph.D.	Senior VP & Head of Neuroimmunology

Important FAQs about investing in VIGL Stock from India :

What is Vigil Neuroscience share price today?

Vigil Neuroscience share price today stands at $1.71, Open: $1.50 ; Previous Close: $1.51 ; High: $1.74 ; Low: $1.50 ; 52 Week High: $6.06 ; 52 Week Low: $1.31.

The stock opens at $1.50, after a previous close of $1.51. The stock reached a daily high of $1.74 and a low of $1.50, with a 52-week high of $6.06 and a 52-week low of $1.31.

Can Indians buy Vigil Neuroscience shares?

Yes, Indians can invest in the Vigil Neuroscience (VIGL) from India.

With INDmoney, you can buy Vigil Neuroscience at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vigil Neuroscience at zero transaction cost.

How can I buy Vigil Neuroscience shares from India?

It is very easy to buy Vigil Neuroscience from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vigil Neuroscience (VIGL) be purchased?

Yes, you can buy fractional shares of Vigil Neuroscience with INDmoney app.

What are the documents required to start investing in Vigil Neuroscience stocks?

To start investing in Vigil Neuroscience, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.